Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Drug development

09.10.2024

Reducing the use of animals in toxicological research with data science and artificial intelligence

14.08.2024

Solving the puzzle of membrane receptors

Protein model
31.05.2024

G proteins, schizophrenia and potential new drugs

29.11.2023

Animal experimentation in toxicology for the 21st century: needed or outdated?

29.08.2023

The eTRANSAFE project finishes with a huge database and a drug safety predictive tool

16.12.2022

Treatment to improve cognitive function in Down’s syndrome on a clinical trial

19.04.2022

A technique that could revolutionize drug development

29.11.2021

A strategic agreement to accelerate the development of new drugs

cannabis plant and pills
23.07.2021

David Andreu (DCEXS-UPF): “Cannabis co-administered with the drug we have developed would offer analgesia without cognitive side effects”

Iris L. Matilla Vaz es enfermera en la unidad de investigación clínica del IMIM, donde se realizan ensayos clínicos en fase I.
20.05.2021

Iris Lioba Matilla Vaz (IMIM): “Without clinical trials, medicine could not move forward”

Understanding the key role of arrestin in the intracellular signalling process. Image courtesy of GPCR drug discovery .
28.09.2020

Deciphering the cell signalling code: the role of β-arrestins

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.
22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org